Relationship between metabolic toxicity and efficacy of everolimus in patients with neuroendocrine tumors (NETs): a pooled analysis from the randomized, phase 3 RADIANT-3, and RADIANT-4 trials
Fazio, N Carnaghi, C Herbst, F Ridolfi, A Strosberg, J Kulke, M Pavel, M Yao, J
Fazio, N
Carnaghi, C
Herbst, F
Ridolfi, A
Strosberg, J
Kulke, M
Pavel, M
Yao, J
Citations
Altmetric:
Abstract
Description
Date
2019
Publisher
Collections
Keywords
Type
Meetings and Proceedings
Citation
Fazio N, Carnaghi C, Valle JW, Herbst F, Ridolfi A, Strosberg J, et al. Relationship between metabolic toxicity and efficacy of everolimus in patients with neuroendocrine tumors (NETs): a pooled analysis from the randomized, phase 3 RADIANT-3, and RADIANT-4 trials. Pancreas. 2019; 48(3):433.